Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.

TheMotleyFool

0 0

Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.: https://g.foolcdn.com/editorial/images/781806/gettyimages-1441663123.jpg

Eli Lilly (NYSE: LLY) is one of the hottest pharmaceutical companies in the world. The company is quickly gaining steam in the weight loss market thanks to its blockbuster drug, Mounjaro, and its sibling treatment, Zepbound.

In addition, earlier this month a group of external advisors to the Food and Drug Administration (FDA) endorsed the use of Lilly's Alzheimer's candidate, donanemab.

While this was encouraging, Lilly just unveiled even more good news. The company is teaming up with OpenAI in an effort to spearhead its drug discovery efforts.

Source Fool.com

Like: 0

LLY

Share